- Sell Strides Arcolab with a target of Rs 990: Mitesh Thacker
'Strides Arcolab is a 'SELL' call with a target of Rs 990 and a stop loss of Rs 1,080'
Strides Arcolab surges as company to buy some Australia drug assets from South Africa's Aspen Pharmacare; ends 8% higherStrides Arcolab today said it will acquire South Africa's Aspen Pharmacare's portfolio of branded and generics products in Australia for ab...
- Buy Strides Arcolab with a target of Rs 1,060: Ashwani Gujral
'Buy Strides Arcolab with a target of Rs 1,010 and a stop loss of Rs 960'
- Sell Strides Arcolab with a stop loss of Rs 883: Mitesh Thacker
Strides Arcolab Ltd is a 'SELL' call with a target of Rs 825 and a stop loss of Rs 883.
- Sell Strides Arcolab with a target of Rs 880: Mitesh Thacker
"Strides Arcolab Ltd is a 'SELL' call with a target of Rs 880 and a stop loss of Rs 926.80"
- Buy Strides Arcolab with a target of Rs 1050: Ashwani Gujral
Strides Arcolab is a 'BUY' call with a target of Rs 1050.
- Buy Strides Arcolab Ltd with a target of Rs 985: Mitesh Thacker
"Strides Arcolab Ltd is a ‘BUY’ call with a target of Rs 985 and a stop loss of Rs 919."
- Buy Strides Arcolab with a target of Rs 1020: Prakash Gaba
'Strides Arcolab is a 'BUY' call with a target of Rs 1020 and a stop loss of Rs 934.
- Buy Strides Arcolab with a target of Rs 810: Prakash Gaba
"Strides Arcolab is 'Buy' call with a target of Rs 810 and a stop loss of Rs 785."
- Buy Strides Arcolab with a target of Rs 810: Prakash Gaba
"Strides Arcolab is a 'Buy' call with a target of Rs 810 and a stop loss of Rs 777."
Strides Arcolab invests in Oncobiologics Inc, acquires stakeShares of Strides Arcolab were today trading at Rs 667.60 per scrip in the morning trade on BSE, up 2.54 per cent from its previous close.
- Buy Strides Arcolab with a target of Rs 670: Prakash Gaba
"Strides Arcolab is a 'BUY' call with a target of Rs 670 and a stop loss of Rs 570."
- Buy Strides Arcolab with a target of Rs 600: Ashwani Gujral
"Strides Arcolab Ltd is a 'BUY' call with a target of Rs 600 and a stop loss of Rs 530"
Goldman Sachs sells Strides Arcolab shares for Rs 33.4 croreGoldman Sachs Investments Mauritius today sold 3.80 lakh shares of drug major Strides Arcolab for nearly Rs 33.4 crore in open market.
Financial services firms buy Strides Arcolab scrips worth Rs 66 crBNP Paribas Arbitrage purchased 5.03 lakh shares of Strides Arcolab for an estimated Rs 38.21 crore, as per information available with the ...
- Buy Strides Arcolab with a target of 900: Prakash Gaba
Strides Arcolab Ltd is a ‘BUY’ call with a target of Rs 900 and a stop loss of Rs 845.
- Buy Strides Arcolab with a target of 775-780: Prakash Gaba
Strides Arcolab Ltd is a ‘BUY’ call with a target of Rs 775-780 and a stop loss of Rs 745.